Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.63 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodocarb SCHEMBL114369 | 0.82 | ACHE (0.59) | ACHEEPHX1ALOX15 | |
| SCHEMBL5144907 | 0.81 | ACHE (0.63) | ACHEEPHX1ALOX15 | |
| SCHEMBL19750277 | 0.81 | ACHE (0.63) | ACHEEPHX1ALOX15 | |
| SCHEMBL18998937 | 0.80 | ACHE (0.61) | ACHEEPHX1ALOX15 | |
| SCHEMBL22824279 | 0.80 | ACHE (0.61) | ACHEEPHX1ALOX15 | |
| SCHEMBL10045769 | 0.79 | ACHE (0.70) | ACHEEPHX1ALOX15 | |
| SCHEMBL593415 | 0.78 | ACHE (0.76) | ACHEEPHX1ALOX15 | |
| SCHEMBL6688663 | 0.77 | ACHE (0.53) | ACHEEPHX1 | |
| SCHEMBL3975468 | 0.76 | ACHE (0.88) | ACHEEPHX1 | |
| Hexane SCHEMBL28986114 | 0.76 | ACHE (0.73) | ACHEEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120100361-A1 | ANTISEPTIC COMPOSITION FOR ENGINEERING WOOD PRODUCTION, AND ENGINEERING WOOD | SDS BIOTECH K.K. (JP) | 2012-04-26 | — | — | US | disclosed |
| US-20050148592-A1 | Use of riboflavin and flavin derivatives as chitinase inhibitors | BAYER AKTIENGESELLSCHAFT (DE) | 2005-07-07 | — | — | US | disclosed |
| US-6875766-B2 | Use of riboflavin and flavin derivatives as chitinase inhibitors | BAYER AG (DE) | 2005-04-05 | — | — | US | disclosed |
| US-20030191091-A1 | Use of riboflavin and flavin derivatives as chitinase inhibitors | BAYER AKTIENGESELLSCHAFT (DE) | 2003-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030191091-A1 | Use of riboflavin and flavin derivatives as chitinase inhibitors | BLVRB, CHIA, CHIT1 | ACHE 282/4885EPHX1 230/4885ALOX15 1013/4885 |
| US-20050148592-A1 | Use of riboflavin and flavin derivatives as chitinase inhibitors | BLVRB, CHIA, CHIT1 | ACHE 282/4885EPHX1 230/4885ALOX15 1013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.